Want to see BOLD full AI Analyst Report?
Boundless Bio Inc. (BOLD) Stock Statistics & Valuation Metrics
Total Valuation
Boundless Bio Inc. has a market cap or net worth of $56.19M. The enterprise value is -$16.50M.
- Market Cap
- $56.19M
- Enterprise Value
- -$16.50M
Share Statistics
Boundless Bio Inc. has 22,747,986 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,747,986
- Owned by Insiders
- 39.85%
- Owned by Institutions
- 13.37%
Financial Efficiency
Boundless Bio Inc.’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -43.03%.
- Return on Equity (ROE)
- -0.59
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -43.03%
- Return on Capital Employed (ROCE)
- -0.44
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.08M
- Employee Count
- 28
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Boundless Bio Inc. is -0.85. Boundless Bio Inc.’s PEG ratio is -0.71.
- PE Ratio
- -0.85
- PS Ratio
- 0.00
- PB Ratio
- 0.83
- Price to FCF
- -0.98
- Price to Operating Cash Flow
- -0.97
- PEG Ratio
- -0.71
Income Statement
In the last 12 months, Boundless Bio Inc. had revenue of 0 and earned -58.20M in profits. Earnings per share was -2.60.
- Revenue
- 0
- Gross Profit
- -1.25M
- Operating Income
- -63.55M
- Pretax Income
- -58.20M
- Net Income
- -58.20M
- EBITDA
- -56.95M
- Earnings Per Share (EPS)
- -2.60
Cash Flow
In the last 12 months, operating cash flow was -56.25M and capital expenditures -485,000, giving a free cash flow of -56.73M billion.
- Operating Cash Flow
- -56.25M
- Free Cash Flow
- -56.73M
- Free Cash Flow per Share
- -2.53
Dividends & Yields
Boundless Bio Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -101.17%
- Earnings Yield
- -115.67%
Stock Price Statistics
- Beta
- 1.15
- 52-Week Price Change
- 74.29%
- 50-Day Moving Average
- 2.66
- 200-Day Moving Average
- 1.93
- Relative Strength Index (RSI)
- 44.10
- Average Volume (3m)
- 174.61K
Important Dates
Boundless Bio Inc. upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Boundless Bio Inc. as a current ratio of 8.74, with Debt / Equity ratio of 49.70%
- Current Ratio
- 8.74
- Quick Ratio
- 8.74
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.55
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Boundless Bio Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Boundless Bio Inc. EV to EBITDA ratio is -0.58, with an EV/FCF ratio of -0.63.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.58
- EV to Free Cash Flow
- -0.63
- EV to Operating Cash Flow
- -0.64
Balance Sheet
Boundless Bio Inc. has $72.63M in cash and marketable securities with $0.00 in debt, giving a net cash position of $72.63M billion.
- Cash & Marketable Securities
- $72.63M
- Total Debt
- $0.00
- Net Cash
- $72.63M
- Net Cash Per Share
- $3.19
- Tangible Book Value Per Share
- $2.94
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Boundless Bio Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 1.11%
Scores
- Smart Score
- 7
- AI Score
- 48
